Literature DB >> 23839027

A review of human drug self-administration procedures.

Jermaine D Jones1, Sandra D Comer.   

Abstract

Drug self-administration procedures in laboratory settings allow us to closely model drug-taking behavior in real-world settings. This review provides an overview of many of the common self-administration methods used in human laboratory research. Typically, self-administration studies provide a quantifiable measure of the reinforcing effect of a drug, which is believed to be predictive of its potential for abuse. Several adaptations of the self-administration paradigm exist, the simplest of which allows participants free access to the drug under investigation. Free-access procedures allow investigators to observe patterns of drug self-administration and drug effects in a controlled setting. Allowing participants to choose between two simultaneously available reinforcers (choice procedures) is another well-established method of assessing the reinforcing effects of a drug. Offering a choice between two reinforcers (e.g. two different doses of the same drug, two different drugs, or drug and nondrug reinforcers) provides researchers with a point of comparison (e.g. between a drug of known abuse potential and a novel drug). When combined with other endpoints, such as subjective effects ratings, physiological responses, and cognitive performance, human self-administration paradigms have contributed significantly to our understanding of the factors that contribute to, maintain, and alter drug-taking behavior including: craving, positive subjective effects, toxicity, drug interactions and abstinence. This area of research has also begun to incorporate other techniques such as imaging and genetics to further understand the multifaceted nature of substance abuse. The present paper summarizes the different self-administration techniques that are commonly used today and the application of other procedures that may complement interpretation of the drug self-administration findings.

Entities:  

Mesh:

Year:  2013        PMID: 23839027      PMCID: PMC4080726          DOI: 10.1097/FBP.0b013e3283641c3d

Source DB:  PubMed          Journal:  Behav Pharmacol        ISSN: 0955-8810            Impact factor:   2.293


  98 in total

1.  Behavioral economics (Editorial).

Authors:  W K Bickel; L Green; R E Vuchinich
Journal:  J Exp Anal Behav       Date:  1995-11       Impact factor: 2.468

2.  Facilitation of human tobacco self-administration by ethanol: a behavioral analysis.

Authors:  R R Griffiths; G E Bigelow; I Liebson
Journal:  J Exp Anal Behav       Date:  1976-05       Impact factor: 2.468

3.  Using a novel alternative to drug choice in a human laboratory model of a cocaine binge: a game of chance.

Authors:  Suzanne K Vosburg; Margaret Haney; Eric Rubin; Richard W Foltin
Journal:  Drug Alcohol Depend       Date:  2010-03-25       Impact factor: 4.492

4.  Effects of 24 hours of tobacco withdrawal and subsequent tobacco smoking among low and high sensation seekers.

Authors:  Dustin C Lee; Kenneth A Perkins; Eli Zimmerman; Glenn Robbins; Thomas H Kelly
Journal:  Nicotine Tob Res       Date:  2011-06-20       Impact factor: 4.244

5.  Experimental analysis of drinking behavior of chronic alcoholics.

Authors:  J H Mendelson; N K Mello
Journal:  Ann N Y Acad Sci       Date:  1966-09-23       Impact factor: 5.691

6.  Effects of buprenorphine on the self-administration of cocaine by humans.

Authors:  R.W. Foltin; M.W. Fischman
Journal:  Behav Pharmacol       Date:  1994-02       Impact factor: 2.293

7.  Survey assessment of methadone treatment services as reinforcers.

Authors:  M A Chutuape; K Silverman; M L Stitzer
Journal:  Am J Drug Alcohol Abuse       Date:  1998-02       Impact factor: 3.829

8.  Reinforcing effects of extended inhalation of a low nitrous oxide concentration in humans.

Authors:  C S Dohrn; J L Lichtor; D W Coalson; D Flemming; J P Zacny
Journal:  Pharmacol Biochem Behav       Date:  1993-12       Impact factor: 3.533

9.  Propofol at a subanesthetic dose may have abuse potential in healthy volunteers.

Authors:  J P Zacny; J L Lichtor; W Thompson; J L Apfelbaum
Journal:  Anesth Analg       Date:  1993-09       Impact factor: 5.108

10.  Preclinical Determinants of Drug Choice under Concurrent Schedules of Drug Self-Administration.

Authors:  Matthew L Banks; S Stevens Negus
Journal:  Adv Pharmacol Sci       Date:  2012-11-28
View more
  25 in total

Review 1.  Neural underpinnings of maladaptive decision-making in addictions.

Authors:  Zoe Guttman; Scott J Moeller; Edythe D London
Journal:  Pharmacol Biochem Behav       Date:  2017-06-27       Impact factor: 3.533

Review 2.  Pharmacotherapies for decreasing maladaptive choice in drug addiction: Targeting the behavior and the drug.

Authors:  Frank N Perkins; Kevin B Freeman
Journal:  Pharmacol Biochem Behav       Date:  2017-06-27       Impact factor: 3.533

Review 3.  Intracranial self-stimulation to evaluate abuse potential of drugs.

Authors:  S Stevens Negus; Laurence L Miller
Journal:  Pharmacol Rev       Date:  2014-07       Impact factor: 25.468

Review 4.  Modeling the development of drug addiction in male and female animals.

Authors:  Wendy J Lynch
Journal:  Pharmacol Biochem Behav       Date:  2017-06-15       Impact factor: 3.533

5.  The reinforcing and subjective effects of intravenous and intranasal buprenorphine in heroin users.

Authors:  Jermaine D Jones; Gabriela Madera; Sandra D Comer
Journal:  Pharmacol Biochem Behav       Date:  2014-05-02       Impact factor: 3.533

6.  A Forced-Choice Procedure to Assess the Acute Relative Reinforcing Effects of Nicotine Dose per se in Humans.

Authors:  Kenneth A Perkins; Joshua L Karelitz
Journal:  Nicotine Tob Res       Date:  2020-10-08       Impact factor: 4.244

7.  Maintenance on naltrexone+amphetamine decreases cocaine-vs.-food choice in male rhesus monkeys.

Authors:  Megan J Moerke; Matthew L Banks; Kejun Cheng; Kenner C Rice; S Stevens Negus
Journal:  Drug Alcohol Depend       Date:  2017-10-13       Impact factor: 4.492

8.  Sex differences in stress reactivity after intranasal oxytocin in recreational cannabis users.

Authors:  Stephanie C Reed; Margaret Haney; Jeanne Manubay; Bianca R Campagna; Brian Reed; Richard W Foltin; Suzette M Evans
Journal:  Pharmacol Biochem Behav       Date:  2018-12-04       Impact factor: 3.533

Review 9.  Fentanyl: Receptor pharmacology, abuse potential, and implications for treatment.

Authors:  Sandra D Comer; Catherine M Cahill
Journal:  Neurosci Biobehav Rev       Date:  2018-12-05       Impact factor: 8.989

10.  The effects of heroin administration and drug cues on impulsivity.

Authors:  Jermaine D Jones; Nehal P Vadhan; Rachel R Luba; Sandra D Comer
Journal:  J Clin Exp Neuropsychol       Date:  2016-04-10       Impact factor: 2.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.